Bu-Fei Yi-Shen Granules Reduce Acute Exacerbations in Patients with GOLD 3–4 COPD: A Randomized Controlled Trial

The Burden of COPD in China and Its Provinces: Findings From the Global Burden of Disease Study 2019

(2022) Peng Yin et al.   Frontiers in Public Health

Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety

(2022) Samy Suissa et al.   International Journal of Chronic Obstructive Pulmonary Disease

Efficiency and Safety of Baofei Granules in Chronic Obstructive Pulmonary Disease (Lung and Spleen Qi Deficiency Syndrome): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial

(2022) Yuan Sun et al.   Drug Design Development and Therapy

Efficacy of Shenling Baizhu San on stable chronic obstructive pulmonary disease patients: A systematic review and meta-analysis

(2021) Yuquan Mao et al.   JOURNAL OF ETHNOPHARMACOLOGY

Triple Inhaler versus Dual Bronchodilator Therapy in COPD: Real-World Effectiveness on Mortality

(2021) Samy Suissa et al.   COPD-Journal of Chronic Obstructive Pulmonary Disease

Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

(2020) Joan B Soriano et al.   Lancet Respiratory Medicine

The Impact of Depression and Anxiety on Chronic Obstructive Pulmonary Disease Acute Exacerbations: A prospective cohort study

(2020) Juan Huang et al.   JOURNAL OF AFFECTIVE DISORDERS

Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study

(2018) Chen Wang et al.   LANCET

Chronic obstructive pulmonary disease in China: a nationwide prevalence study

(2018) Liwen Fang et al.   Lancet Respiratory Medicine

Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial

(2018) Gary T Ferguson et al.   Lancet Respiratory Medicine

Determining prognosis in acute exacerbation of COPD

(2017) Yves Flattet et al.   International Journal of Chronic Obstructive Pulmonary Disease

Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort

(2017) MeiLan K Han et al.   Lancet Respiratory Medicine

Risk factors for exacerbation in chronic obstructive pulmonary disease: a prospective study

(2016) J. Montserrat-Capdevila et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Persistent disabling breathlessness in chronic obstructive pulmonary disease

(2016) Josefin Sundh et al.   International Journal of Chronic Obstructive Pulmonary Disease

Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD

(2015) Ciro Casanova et al.   CHEST

Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit

(2015) Sylvia Hartl et al.   EUROPEAN RESPIRATORY JOURNAL

The COPD assessment test (CAT) assists prediction of COPD exacerbations in high-risk patients

(2014) Sang-Do Lee et al.   RESPIRATORY MEDICINE

Evidence suggesting that oral corticosteroids increase mortality in stable chronic obstructive pulmonary disease

(2014) Nobuyuki Horita et al.   RESPIRATORY RESEARCH

The effective evaluation on symptoms and quality of life of chronic obstructive pulmonary disease patients treated by comprehensive therapy based on traditional Chinese medicine patterns

(2013) Jian-sheng Li et al.   COMPLEMENTARY THERAPIES IN MEDICINE

Effects of comprehensive therapy based on traditional Chinese medicine patterns in stable chronic obstructive pulmonary disease: a four-center, open-label, randomized, controlled study

(2012) Su-yun Li et al.   BMC Complementary and Alternative Medicine

Effect of sequential treatment with syndrome differentiation on acute exacerbation of chronic obstructive pulmonary disease and "AECOPD Risk-Window": study protocol for a randomized placebo-controlled trial

(2012) Wang Haifeng et al.   Trials